These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5340322)

  • 1. Clinical pharmacology--a review. Federal Drug Regulations and their impact on clinical pharmacology.
    Pallasch TJ
    J Oral Ther Pharmacol; 1966 Sep; 3(2):136-48 concl. PubMed ID: 5340322
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA seeks tighter controls over research with human subjects.
    Hershey N; Miller RD
    Hosp Med Staff; 1978 Dec; 7(12):1-7. PubMed ID: 10239337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Federal report says protection of human subjects is threatened by numerous factors.
    Maloney DM
    Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Final rule.
    Fed Regist; 1991 Jun; 56(117):28025-9. PubMed ID: 10112215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OPRR and FDA propose revised expedited review categories.
    McGough H
    IRB; 1998; 20(1):9, 11. PubMed ID: 11655326
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of institutional review boards on clinical research.
    Levine RJ
    Perspect Biol Med; 1980 Pt 2): S99-S114, Winter; 23(2):. PubMed ID: 11663073
    [No Abstract]   [Full Text] [Related]  

  • 7. Department of Health and Human Services regulations affecting psychopharmacology research.
    Reatig N
    Psychopharmacol Bull; 1981 Apr; 17(2):56-65. PubMed ID: 7244062
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA revises informed consent regulations for emergency research.
    Menasché A; Levine RJ
    IRB; 1995; 17(5-6):19-22. PubMed ID: 11653359
    [No Abstract]   [Full Text] [Related]  

  • 9. When do the federal regulations allow placebo-controlled trials in children?
    Miller FG; Wendler D; Wilfond B
    J Pediatr; 2003 Feb; 142(2):102-7. PubMed ID: 12584527
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Proposed rule.
    Fed Regist; 1988 Nov; 53(218):45678-82. PubMed ID: 10290533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Federal agency keeps review committee after public comments support continuation.
    Maloney DM
    Hum Res Rep; 1997 Jan; 12(1):1-2. PubMed ID: 11654603
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA overview and current challenges in regulation of human subject protection. Food and Drug Administration.
    Nightingale SL
    J Int Assoc Physicians AIDS Care; 1997 Jan; 3(1):24-6. PubMed ID: 11363959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two rules on expedited IRB reviews are final.
    Maloney DM
    Hum Res Rep; 1999 Jan; 14(1):3. PubMed ID: 11657557
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of human subjects; proposed establishment of regulations.
    Fed Regist; 1979 Apr; 44(80):24106-11. PubMed ID: 10241036
    [No Abstract]   [Full Text] [Related]  

  • 15. IRB review of adverse events in investigational drug studies.
    Prentice ED; Gordon B
    IRB; 1997; 19(6):1-4. PubMed ID: 11656910
    [No Abstract]   [Full Text] [Related]  

  • 16. Reflections on the FDA's intraocular lens regulations.
    Worthen DM
    IRB; 1980 Apr; 2(4):1-3. PubMed ID: 11661783
    [No Abstract]   [Full Text] [Related]  

  • 17. The history of institutional review boards.
    Sherman M; Van Vleet JD
    Regul Aff J; 1991; 3():615-27. PubMed ID: 11651491
    [No Abstract]   [Full Text] [Related]  

  • 18. Research compliance changes will affect rules on protection of human subjects.
    Maloney DM
    Hum Res Rep; 1999 May; 14(5):1-2. PubMed ID: 11657776
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethics of private panels comes under scrutiny.
    Wadman M
    Nature; 1997 May; 387(6632):445. PubMed ID: 9168099
    [No Abstract]   [Full Text] [Related]  

  • 20. An overview of FDA, IRBs and regulations.
    Petricciani JC
    IRB; 1981 Dec; 3(10):1-3, 11. PubMed ID: 11649413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.